Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Bupropion shows benefit for cancer-related fatigue in cancer survivors

Dr Luke Joseph Peppone - University of Rochester Medical Center, Rochester, USA
Bupropion shows benefit for cancer-related fatigue in cancer survivors ( Dr Luke Joseph Peppone - University of Rochester Medical Center, Rochester, USA )
1 Jun 2026

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada
Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer ( Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada )
1 Jun 2026

Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety

Dr Atsuo Takashima - National Cancer Center Hospital, Tokyo, Japan
Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety ( Dr Atsuo Takashima - National Cancer Center Hospital, Tokyo, Japan )
1 Jun 2026

Short-term fasting linked to improved chemo response in advanced ovarian cancer

Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy
Short-term fasting linked to improved chemo response in advanced ovarian cancer ( Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy )
1 Jun 2026

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer

Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )
1 Jun 2026

ASCO 2026: Latest in prostate cancer

Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger
ASCO 2026: Latest in prostate cancer ( Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger )
1 Jun 2026

Amivantamab in HPV-unrelated mHNSCC gives high response rates after immunotherapy and chemo

Dr Barbara Burtness - Yale Cancer Center, New Haven, USA
Amivantamab in HPV-unrelated mHNSCC gives high response rates after immunotherapy and chemo ( Dr Barbara Burtness -  Yale Cancer Center, New Haven, USA )
1 Jun 2026

Structured exercise programme improves survival and reduces healthcare costs in colon cancer

Dr Kelvin K. Chan - Sunnybrook Odette Cancer Centre, Toronto, Canada
Structured exercise programme improves survival and reduces healthcare costs in colon cancer ( Dr Kelvin K. Chan - Sunnybrook Odette Cancer Centre, Toronto, Canada )
1 Jun 2026

Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission

Dr Robert Stein - University College London, London, UK
Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission ( Dr Robert Stein - University College London, London, UK )
1 Jun 2026

Weight loss intervention improves quality of life in breast cancer survivors

Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA
Weight loss intervention improves quality of life in breast cancer survivors ( Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2026

Adjuvant avelumab reduces relapse risk in stage III Merkel cell carcinoma

Dr Shailender Bhatia - Fred Hutchinson Cancer Center, Seattle, USA
Adjuvant avelumab reduces relapse risk in stage III Merkel cell carcinoma ( Dr Shailender Bhatia - Fred Hutchinson Cancer Center, Seattle, USA )
1 Jun 2026

Fedratinib improves spleen and symptom responses with promising survival outcomes in MDS/MPN and CNL

Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA
Fedratinib improves spleen and symptom responses with promising survival outcomes in MDS/MPN and CNL ( Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA )
1 Jun 2026